504 related articles for article (PubMed ID: 25800776)
1. Effect of serum choice on replicative senescence in mesenchymal stromal cells.
Liu Y; Li YQ; Wang HY; Li YJ; Liu GY; Xu X; Wu XB; Jing YG; Yao Y; Wu CT; Jin JD
Cytotherapy; 2015 Jul; 17(7):874-84. PubMed ID: 25800776
[TBL] [Abstract][Full Text] [Related]
2. A critical appraisal of humanized alternatives to fetal bovine serum for clinical applications of umbilical cord derived mesenchymal stromal cells.
Rallapalli S; Guhathakurta S; Bishi DK; Subbarayan R; Mathapati S; Korrapati PS
Biotechnol Lett; 2021 Oct; 43(10):2067-2083. PubMed ID: 34499291
[TBL] [Abstract][Full Text] [Related]
3. Differential Development of Umbilical Cord-Derived Mesenchymal Stem Cells During Long-Term Maintenance in Fetal Bovine Serum-Supplemented Medium and Xeno- and Serum-Free Culture Medium.
Le HM; Nguyen LT; Hoang DH; Bach TQ; Nguyen HTN; Mai HT; Trinh DP; Nguyen TD; Nguyen LT; Than UTT
Cell Reprogram; 2021 Dec; 23(6):359-369. PubMed ID: 34748399
[TBL] [Abstract][Full Text] [Related]
4. Phenotypical and functional characteristics of mesenchymal stem cells from bone marrow: comparison of culture using different media supplemented with human platelet lysate or fetal bovine serum.
Ben Azouna N; Jenhani F; Regaya Z; Berraeis L; Ben Othman T; Ducrocq E; Domenech J
Stem Cell Res Ther; 2012 Feb; 3(1):6. PubMed ID: 22333342
[TBL] [Abstract][Full Text] [Related]
5. Human serum enhances the proliferative capacity and immunomodulatory property of MSCs derived from human placenta and umbilical cord.
Thaweesapphithak S; Tantrawatpan C; Kheolamai P; Tantikanlayaporn D; Roytrakul S; Manochantr S
Stem Cell Res Ther; 2019 Mar; 10(1):79. PubMed ID: 30845980
[TBL] [Abstract][Full Text] [Related]
6. Nanofiltration of growth media supplemented with human platelet lysates for pathogen-safe xeno-free expansion of mesenchymal stromal cells.
Barro L; Nebie O; Chen MS; Wu YW; Koh MB; Knutson F; Watanabe N; Takahara M; Burnouf T
Cytotherapy; 2020 Aug; 22(8):458-472. PubMed ID: 32536505
[TBL] [Abstract][Full Text] [Related]
7. [Comparison of the biological characteristics of serum-free and fetal bovine serum-contained medium cultured umbilical cord-derived mesenchymal stem cells].
Yang T; Chen GH; Xue SL; Qiao M; Liu HW; Tian H; Qiao SM; Chen F; Chen ZZ; Sun AN; Wu DP
Zhonghua Xue Ye Xue Za Zhi; 2012 Sep; 33(9):715-9. PubMed ID: 23336223
[TBL] [Abstract][Full Text] [Related]
8. SIRT1-dependent anti-senescence effects of cell-deposited matrix on human umbilical cord mesenchymal stem cells.
Zhou L; Chen X; Liu T; Zhu C; Si M; Jargstorf J; Li M; Pan G; Gong Y; Luo ZP; Yang H; Pei M; He F
J Tissue Eng Regen Med; 2018 Feb; 12(2):e1008-e1021. PubMed ID: 28107614
[TBL] [Abstract][Full Text] [Related]
9. Culturing on Wharton's jelly extract delays mesenchymal stem cell senescence through p53 and p16INK4a/pRb pathways.
Hao H; Chen G; Liu J; Ti D; Zhao Y; Xu S; Fu X; Han W
PLoS One; 2013; 8(3):e58314. PubMed ID: 23516461
[TBL] [Abstract][Full Text] [Related]
10. Nature vs. Nurture: Defining the Effects of Mesenchymal Stromal Cell Isolation and Culture Conditions on Resiliency to Palmitate Challenge.
Boland LK; Burand AJ; Boyt DT; Dobroski H; Di L; Liszewski JN; Schrodt MV; Frazer MK; Santillan DA; Ankrum JA
Front Immunol; 2019; 10():1080. PubMed ID: 31134100
[TBL] [Abstract][Full Text] [Related]
11. Human umbilical cord blood plasma as an alternative to animal sera for mesenchymal stromal cells in vitro expansion - A multicomponent metabolomic analysis.
Caseiro AR; Ivanova G; Pedrosa SS; Branquinho MV; Georgieva P; Barbosa PP; Santos JD; Magalhães R; Teixeira P; Pereira T; Maurício AC
PLoS One; 2018; 13(10):e0203936. PubMed ID: 30304014
[TBL] [Abstract][Full Text] [Related]
12. Replicative aging and differentiation potential of human adipose tissue-derived mesenchymal stromal cells expanded in pooled human or fetal bovine serum.
Bieback K; Hecker A; Schlechter T; Hofmann I; Brousos N; Redmer T; Besser D; Klüter H; Müller AM; Becker M
Cytotherapy; 2012 May; 14(5):570-83. PubMed ID: 22300364
[TBL] [Abstract][Full Text] [Related]
13. Herbal pre-conditioning induces proliferation and delays senescence in Wharton's Jelly Mesenchymal Stem Cells.
Sanap A; Chandravanshi B; Shah T; Tillu G; Dhanushkodi A; Bhonde R; Joshi K
Biomed Pharmacother; 2017 Sep; 93():772-778. PubMed ID: 28724259
[TBL] [Abstract][Full Text] [Related]
14. Altered gene expression in human adipose stem cells cultured with fetal bovine serum compared to human supplements.
Bieback K; Ha VA; Hecker A; Grassl M; Kinzebach S; Solz H; Sticht C; Klüter H; Bugert P
Tissue Eng Part A; 2010 Nov; 16(11):3467-84. PubMed ID: 20572797
[TBL] [Abstract][Full Text] [Related]
15. Choice of xenogenic-free expansion media significantly influences the myogenic differentiation potential of human bone marrow-derived mesenchymal stromal cells.
Brun J; Abruzzese T; Rolauffs B; Aicher WK; Hart ML
Cytotherapy; 2016 Mar; 18(3):344-59. PubMed ID: 26857228
[TBL] [Abstract][Full Text] [Related]
16. The effects of culture conditions on the functionality of efficiently obtained mesenchymal stromal cells from human cord blood.
Laitinen A; Lampinen M; Liedtke S; Kilpinen L; Kerkelä E; Sarkanen JR; Heinonen T; Kogler G; Laitinen S
Cytotherapy; 2016 Mar; 18(3):423-37. PubMed ID: 26857232
[TBL] [Abstract][Full Text] [Related]
17. Umbilical cord tissue-derived mesenchymal stem cells grow best under GMP-compliant culture conditions and maintain their phenotypic and functional properties.
Hartmann I; Hollweck T; Haffner S; Krebs M; Meiser B; Reichart B; Eissner G
J Immunol Methods; 2010 Dec; 363(1):80-9. PubMed ID: 21035451
[TBL] [Abstract][Full Text] [Related]
18. Human umbilical cord serum as an alternative to fetal bovine serum for in vitro expansion of umbilical cord mesenchymal stromal cells.
Afzal E; Pakzad M; Nouri M; Moghadasali R; Zarrabi M
Cell Tissue Bank; 2023 Mar; 24(1):59-66. PubMed ID: 35635634
[TBL] [Abstract][Full Text] [Related]
19. Human platelet lysate stimulates high-passage and senescent human multipotent mesenchymal stromal cell growth and rejuvenation in vitro.
Griffiths S; Baraniak PR; Copland IB; Nerem RM; McDevitt TC
Cytotherapy; 2013 Dec; 15(12):1469-83. PubMed ID: 23981539
[TBL] [Abstract][Full Text] [Related]
20. Regulatory-compliant conditions during cell product manufacturing enhance in vitro immunomodulatory properties of infrapatellar fat pad-derived mesenchymal stem/stromal cells.
Kouroupis D; Bowles AC; Greif DN; Leñero C; Best TM; Kaplan LD; Correa D
Cytotherapy; 2020 Nov; 22(11):677-689. PubMed ID: 32723596
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
